• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Executive Changes In Cannabis Industry You Should Know About, New Appointments & More

    7/3/24 1:08:06 PM ET
    $LFST
    $RIV
    Medical/Nursing Services
    Health Care
    Finance Companies
    Finance
    Get the next $LFST alert in real time by email

    As the 19th Benzinga Cannabis Capital Conference, returns (Oct. 8-9) in Chicago, gathering top CEOs, investors, and leaders in the cannabis industry, let’s scroll through the latest leadership changes within the space. Get your tickets now before prices go up by following this link.

    Cannabis Board Updates

    Shareholders of four cannabis companies held their respective annual meetings, electing nominees as board directors.

    Auxly Cannabis Group Inc. (TSX:XLY) (OTCQB:CBWTF) said on Tuesday that each of the directors listed as a nominee in the circular was elected as a director of the company, including:

    • Genevieve Young; 
    • Hugo Alves;
    • Troy Grant;
    • Vikram Bawa; and
    • Conrad Tate.

    iAnthus Capital Holdings, Inc.'s (CSE:IAN) (OTCQB:ITHUF) shareholders approved the election of Scott Cohen, Michelle Mathews-Spradlin, Kenneth W. Gilbert, Alexander Shoghi and Richard Proud as directors of the company.

    The shareholders at the cannabinoids-focused pharmaceutical company MediPharm Labs Corp. (TSX:LABS) (OTCQX:MEDIF) (FSE: MLZ) elected the following experts as members of the board of directors:

    • Michael Bumby;
    • Chris Halyk;
    • David Pidduck;
    • Shelley Potts; and
    • Chris Taves.

    Vertically integrated cannabis company Glass House Brands Inc.'s shareholders (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX:GLASF) (OTCQX:GHBWF) elected all seven nominees for the board of directors, including:

    • Kyle Kazan;
    • Graham Farrar;
    • John Nichols Jr.;
    • Humble Lukanga;
    • Jocelyn Rosenwald;
    • George Raveling; and
    • Yelena Katchko.

    Meanwhile, Sandy Li, who has been serving at cannabis edibles producer Wana Brands for over two years as chief finance officer, joined the advisory board at Viridian Capital Advisors. Before joining Wana, Li was head of FP&A and treasury at Parallel, a multi-state cannabis operator.

    Scott Greiper, CEO and founder of Viridian Capital said Sandy Li is "one of the most accomplished financial executives in the cannabis industry."

    Read Also: Latest Key Hires & Board Changes In Cannabis Industry: Canopy Growth, Acreage And More

    Other Changes Among Industry Leadership

    California cannabis company Lowell Farms Inc. (CSE:LOWL) (OTCQX:LOWLF) announced on Friday that CFO Jamie Schniedwind opted to resign. Mark Ainsworth, the company's CEO has agreed to act as interim CFO, to serve until the company appoints a successor CFO.

    RIV Capital Inc. (CSE:RIV) (OTC:CNPOF) and Cansortium Inc. (CSE:TIUM) (OTCQB:CNTMF), which recently revealed their plan to merge announced last week the appointment of David Vautrinas chief retail officer of RIV Capital. Vautrin, a seasoned CPG expert with vast cannabis experience, will initially oversee retail and wholesale operations in New York, ahead of the anticipated completion of the previously announced business combination with Cansortium, upon which time it is expected that he will assume responsibility for the combined company’s retail footprint.

    SIPP Industries, Inc. (OTC:SIPC) said last week that it has named Adam Graziano as the new CEO. Jakob Jorgensen, the former CEO of the company, will remain a business consultant while also joining Calypso Pharmaceuticals as their new CEO. Jorgensen’s new role will focus on advancing the recent research and development agreement between Calypso Pharmaceuticals and SIPP Industries.

    Lifeist Wellness Inc. (TSXV:LFST) (FRANKFURT: M5B0) (OTC:LFSWF), said on Wednesday that the board of directors has appointed Andrea Judge to the positions of vice president operations of Lifeist and CEO of Mikra Cellular Sciences effective immediately.

     Read Next:

    • Executive Changes In the Marijuana Industry You Should Know About, New Cannabis Appointments & More
    Get the next $LFST alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $LFST
    $RIV

    CompanyDatePrice TargetRatingAnalyst
    LifeStance Health Group Inc.
    $LFST
    12/9/2025$8.00Overweight
    Barclays
    LifeStance Health Group Inc.
    $LFST
    11/13/2025$8.00Outperform
    BMO Capital Markets
    LifeStance Health Group Inc.
    $LFST
    7/25/2025$8.00Buy
    BTIG Research
    LifeStance Health Group Inc.
    $LFST
    5/27/2025$8.50Neutral → Buy
    UBS
    LifeStance Health Group Inc.
    $LFST
    4/8/2025$9.00Overweight
    KeyBanc Capital Markets
    LifeStance Health Group Inc.
    $LFST
    4/3/2025$8.00Buy
    Canaccord Genuity
    LifeStance Health Group Inc.
    $LFST
    12/16/2024$10.00Neutral → Buy
    Goldman
    LifeStance Health Group Inc.
    $LFST
    1/3/2024$7.00Underweight
    Barclays
    More analyst ratings

    $LFST
    $RIV
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: New insider Miller Lisa K claimed ownership of 282,495 shares (SEC Form 3)

    3/A - LifeStance Health Group, Inc. (0001845257) (Issuer)

    1/29/26 4:49:52 PM ET
    $LFST
    Medical/Nursing Services
    Health Care

    Director Bessler Robert sold $856,367 worth of shares (121,643 units at $7.04) (SEC Form 4)

    4 - LifeStance Health Group, Inc. (0001845257) (Issuer)

    12/23/25 7:53:46 PM ET
    $LFST
    Medical/Nursing Services
    Health Care

    Director Bessler Robert sold $45,094 worth of shares (6,442 units at $7.00) (SEC Form 4)

    4 - LifeStance Health Group, Inc. (0001845257) (Issuer)

    12/19/25 4:55:55 PM ET
    $LFST
    Medical/Nursing Services
    Health Care

    $LFST
    $RIV
    SEC Filings

    View All

    SEC Form N-2 filed by RiverNorth Opportunities Fund Inc.

    N-2 - RIVERNORTH OPPORTUNITIES FUND, INC. (0001501072) (Filer)

    2/9/26 9:11:02 PM ET
    $RIV
    Finance Companies
    Finance

    Amendment: SEC Form SCHEDULE 13G/A filed by LifeStance Health Group Inc.

    SCHEDULE 13G/A - LifeStance Health Group, Inc. (0001845257) (Subject)

    2/5/26 1:28:06 PM ET
    $LFST
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by LifeStance Health Group Inc.

    SCHEDULE 13G/A - LifeStance Health Group, Inc. (0001845257) (Subject)

    11/13/25 4:05:02 PM ET
    $LFST
    Medical/Nursing Services
    Health Care

    $LFST
    $RIV
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Burdick Kenneth A bought $498,294 worth of shares (114,181 units at $4.36), increasing direct ownership by 2% to 3,436,571 units (SEC Form 4)

    4 - LifeStance Health Group, Inc. (0001845257) (Issuer)

    8/12/25 4:30:22 PM ET
    $LFST
    Medical/Nursing Services
    Health Care

    $LFST
    $RIV
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Barclays initiated coverage on LifeStance Health Group with a new price target

    Barclays initiated coverage of LifeStance Health Group with a rating of Overweight and set a new price target of $8.00

    12/9/25 8:50:31 AM ET
    $LFST
    Medical/Nursing Services
    Health Care

    BMO Capital Markets initiated coverage on LifeStance Health Group with a new price target

    BMO Capital Markets initiated coverage of LifeStance Health Group with a rating of Outperform and set a new price target of $8.00

    11/13/25 9:14:47 AM ET
    $LFST
    Medical/Nursing Services
    Health Care

    BTIG Research initiated coverage on LifeStance Health Group with a new price target

    BTIG Research initiated coverage of LifeStance Health Group with a rating of Buy and set a new price target of $8.00

    7/25/25 9:06:51 AM ET
    $LFST
    Medical/Nursing Services
    Health Care

    $LFST
    $RIV
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    LifeStance to Host Fourth Quarter and Full Year 2025 Earnings Conference Call on February 25, 2026

    SCOTTSDALE, Ariz., Feb. 09, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, will issue its fourth quarter and full year 2025 earnings release before the market opens on Wednesday, February 25, 2026. LifeStance will host a live earnings conference call to discuss fourth quarter and full year results on February 25, 2026, at 8:30 a.m. Eastern Time. To participate in the call, please dial 1-800-715-9871, domestically, or 1-646-307-1963, internationally, and use conference ID 3993891, or ask to be joined into the LifeStance call. A real-time audio webcast can be accessed via the Events and Presentat

    2/9/26 4:10:00 PM ET
    $LFST
    Medical/Nursing Services
    Health Care

    RiverNorth Closed-End Funds Declare Monthly Distributions

    In accordance with the RiverNorth closed-end funds (the "Funds") level distribution policies, the reset distribution rates have been proposed for the calendar year 2026, as detailed below. Further, the Funds have established the distribution dates for January, February, and March 2026. The payment of the distributions are subject to Board approval. Ex Date Record Date Payable Date 1/15/2026 1/15/2026 1/30/2026 2/13/2026 2/13/2026 2/27/2026 3/16/2026 3/16/2026 3/31/2026 Tax-Exempt Distributions1 Fund Name Ticker Distribution Per Share Net Asset Value (NAV) as of 12/31/2025 Annualize

    1/2/26 4:30:00 PM ET
    $OPP
    $RFM
    $RFMZ
    Finance/Investors Services
    Finance
    Trusts Except Educational Religious and Charitable
    Finance Companies

    Nearly 7 in 10 Americans Feel Pressure to Appear Happier Than They Are This Holiday Season

    LifeStance Survey Reveals How the Holidays Affect Mental Health, with Stress and Social Pressure Hitting Millennials and Gen Z Hardest SCOTTSDALE, Ariz., Nov. 5, 2025 /PRNewswire/ -- Findings from a LifeStance Health survey released today reveal that for many Americans, the holiday season involves a complex mix of emotions, including reported feelings of stress and pressure. These trends are particularly pronounced among younger generations. The survey explored topics commonly addressed in therapy around the holidays, including seasonal stress, navigating social gatherings, pe

    11/5/25 9:00:00 AM ET
    $LFST
    Medical/Nursing Services
    Health Care

    $LFST
    $RIV
    Leadership Updates

    Live Leadership Updates

    View All

    Sarah Personette Appointed to LifeStance Board of Directors

    Director William Miller to Step Down SCOTTSDALE, Ariz., Aug. 22, 2025 /PRNewswire/ -- LifeStance Health (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, today announced the appointment of Sarah Personette, an accomplished customer experience, media and technology executive, to the company's board of directors, effective today. William Miller, Wellsky Chairman and CEO, will step down from the board after five years of service. "Sarah's longstanding focus on understanding consumer behavior to improve the customer experience parallels our com

    8/22/25 9:00:00 AM ET
    $LFST
    Medical/Nursing Services
    Health Care

    LifeStance Names Vaughn Paunovich as Chief Technology Officer

    SCOTTSDALE, Ariz., May 14, 2025 /PRNewswire/ -- LifeStance Health, one of the nation's largest providers of virtual and in-person outpatient mental health care, today announced that Vaughn Paunovich will join the company as Chief Technology Officer, effective Monday, June 9, 2025. Paunovich will lead LifeStance's end-to-end technology strategy, ensuring that the organization continues to deliver a best-in-class technology experience for its patients and clinicians. "Vaughn brings a demonstrated track record of leading high-performing technology teams and delivering digital exp

    5/14/25 9:00:00 AM ET
    $LFST
    Medical/Nursing Services
    Health Care

    NVA Appoints Ken Burdick Executive Chairman Ahead of Future IPO

    Board further strengthened with appointment of Mike McFarland as Director National Veterinary Associates Group ("NVA"), a leading veterinary care organization, today announced it has strengthened its Board with the appointments of Ken Burdick as Executive Chairman and Dr. James "Mike" McFarland as Director. These executives bring substantial healthcare and public company experience ahead of the company's future IPO. Burdick is a seasoned public company executive with more than 40 years of healthcare experience. He currently serves as Executive Chairman at LifeStance Health (NASDAQ:LFST), a leading U.S. provider of outpatient mental healthcare. Since joining LifeStance as Chairman and CEO

    5/7/25 2:00:00 PM ET
    $CNC
    $LFST
    Medical Specialities
    Health Care
    Medical/Nursing Services

    $LFST
    $RIV
    Financials

    Live finance-specific insights

    View All

    LifeStance to Host Fourth Quarter and Full Year 2025 Earnings Conference Call on February 25, 2026

    SCOTTSDALE, Ariz., Feb. 09, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, will issue its fourth quarter and full year 2025 earnings release before the market opens on Wednesday, February 25, 2026. LifeStance will host a live earnings conference call to discuss fourth quarter and full year results on February 25, 2026, at 8:30 a.m. Eastern Time. To participate in the call, please dial 1-800-715-9871, domestically, or 1-646-307-1963, internationally, and use conference ID 3993891, or ask to be joined into the LifeStance call. A real-time audio webcast can be accessed via the Events and Presentat

    2/9/26 4:10:00 PM ET
    $LFST
    Medical/Nursing Services
    Health Care

    RiverNorth Closed-End Funds Declare Monthly Distributions

    In accordance with the RiverNorth closed-end funds (the "Funds") level distribution policies, the reset distribution rates have been proposed for the calendar year 2026, as detailed below. Further, the Funds have established the distribution dates for January, February, and March 2026. The payment of the distributions are subject to Board approval. Ex Date Record Date Payable Date 1/15/2026 1/15/2026 1/30/2026 2/13/2026 2/13/2026 2/27/2026 3/16/2026 3/16/2026 3/31/2026 Tax-Exempt Distributions1 Fund Name Ticker Distribution Per Share Net Asset Value (NAV) as of 12/31/2025 Annualize

    1/2/26 4:30:00 PM ET
    $OPP
    $RFM
    $RFMZ
    Finance/Investors Services
    Finance
    Trusts Except Educational Religious and Charitable
    Finance Companies

    LifeStance to Host Third Quarter 2025 Earnings Conference Call on November 6, 2025

    SCOTTSDALE, Ariz., Oct. 16, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, will issue its third quarter 2025 earnings release before the market opens on Thursday, November 6, 2025. LifeStance will host a live earnings conference call to discuss third quarter results on November 6, 2025, at 8:30 a.m. Eastern Time. To participate in the call, please dial 1-800-715-9871, domestically, or 1-646-307-1963, internationally, and use conference ID 3958273, or ask to be joined into the LifeStance call. A real-time audio webcast can be accessed via the Events and Presentations section of the LifeStance In

    10/16/25 4:10:00 PM ET
    $LFST
    Medical/Nursing Services
    Health Care

    $LFST
    $RIV
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by LifeStance Health Group Inc.

    SC 13G/A - LifeStance Health Group, Inc. (0001845257) (Subject)

    11/14/24 4:34:15 PM ET
    $LFST
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SC 13G/A filed by LifeStance Health Group Inc.

    SC 13G/A - LifeStance Health Group, Inc. (0001845257) (Subject)

    11/14/24 9:59:56 AM ET
    $LFST
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SC 13G/A filed by LifeStance Health Group Inc.

    SC 13G/A - LifeStance Health Group, Inc. (0001845257) (Subject)

    11/8/24 4:33:25 PM ET
    $LFST
    Medical/Nursing Services
    Health Care